Mitochondria provide a key amplification step in the apoptotic pathway of m
any cells by releasing apoptogenic proteins into the cytosol. Recent studie
s have provided insights into how Bar and Bid may operate synergistically t
o recruit mitochondria into the pathway and how GD3 ganglioside, a metaboli
te of the sphingomyelin pathway, may also be used. In ischaemic disease, ac
tivation of the mitochondrial permeability transition pare may bypass the r
equirement for these factors.